A PHASE 1, OPEN-LABEL EVALUATION OF THE PHARMACOKINETICS AND SAFETY OF A SINGLE DOSE OF APRAGLUTIDE IN SUBJECTS WITH NORMAL AND IMPAIRED RENAL FUNCTION

Gerard Greig  1     Danni Cong  2     Niamh Hurley  2     Eric Michel  2     Nader N. Youssef  2    
1 VectivBio, Basel, Switzerland
2 ICON PRA Health Sciences, Dublin, Ireland

Session
Small intestinal (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing